Advertisement
SanguiBioTech GmbH is a wholly owned subsidiary of Sangui BioTechInternational, Inc. (http://www.pinksheets.com: SGBI)
Some of the statements contained in this news release discuss futureexpectations, contain projections of results of operation or financialcondition or state other "forward-looking" information. These statements aresubject to known and unknown risks, uncertainties, and other factors thatcould cause the actual results to differ materially from those contemplatedby the statements. The forward-looking information is based on variousfactors and is derived using numerous assumptions. Important factors that maycause actual results to differ from projections include, among many others,the ability of the Company to raise sufficient capital to meet operatingrequirements. Words such as "anticipates," "expects," "intends," "plans,""believes," "seeks," "estimates," and variations of such words and similarexpressions are intended to identify such forward-looking statements. Unlessrequired by law, the Company undertakes no obligation to update publicly anyforward-looking statements, whether as a result of new information, futureevents or otherwise.For more information please contact: Joachim Fleing Phone: +49-(160)-741-27-17 Fax: +49-(2302)-915-191 e-mail: [email protected]
SOURCE Sangui Bio Tech International Inc.